PCI Biotech: Extension of preclinical research collaboration agreement with a top-10 large pharma company Pharmaceutical Investing
TRACON Pharmaceuticals Announces Positive Data from Ongoing Phase 1b/2 Trial of TRC105 Pharmaceutical Investing
Xtant Medical Enters into Restructuring and Exchange Agreement with All Holders of Outstanding Convertible Notes Medical Device Investing
VBI Vaccines Announces Dosing of First Patient in Phase 1/2a Clinical Study of VBI-1901 Pharmaceutical Investing
Amarin Announces Commencement of VASCEPA® Clinical Development in Mainland China Pharmaceutical Investing
Strongbridge Biopharma Receives Notice of Allowance from U.S. Patent and Trademark Office for New Patent Life Science Investing
Caladrius Biosciences Announces Completion of Enrollment of Phase 2 T-Rex Clinical Trial of CLBS03 for Type 1 Diabetes Pharmaceutical Investing
EnWave Announces Amendment to its Consulting Agreement with Adelaide Capital Markets Life Science Investing
